| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/16/2002 | WO2002038760A2 Regulation of human extracellular calcium-sensing g protein-coupled receptor |
| 05/16/2002 | WO2002038759A2 Method for inducing apoptiosis |
| 05/16/2002 | WO2002038755A1 Circular extra-chromosomal dna elements |
| 05/16/2002 | WO2002038751A2 Ras/p21 transgenic mouse |
| 05/16/2002 | WO2002038750A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
| 05/16/2002 | WO2002038726A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/16/2002 | WO2002038613A2 Modified recombinase |
| 05/16/2002 | WO2002038610A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | WO2002038609A2 Apolipoprotein conjugates |
| 05/16/2002 | WO2002038608A2 Methods of screening for ltrpc2 modulators |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038606A2 Compositions and methods relating to ovary specific genes and proteins |
| 05/16/2002 | WO2002038605A1 A novel peptide---olfactory receptor 27.61 and the polynucleotide encoding this novel peptide |
| 05/16/2002 | WO2002038604A1 A new polypeptide-cicliary rootlet protein 45.98 and the polynucleotide encoding it |
| 05/16/2002 | WO2002038603A1 A novel peptide---human large protein 1225-13.87 and the polynucleotide coding this novel peptide |
| 05/16/2002 | WO2002038602A2 Secreted proteins |
| 05/16/2002 | WO2002038601A2 Foggy |
| 05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | WO2002038599A2 A plant development regulating gene and its uses |
| 05/16/2002 | WO2002038597A2 Genomic fragment of streptococcus suis and clinical uses thereof |
| 05/16/2002 | WO2002038596A1 Method of identifying antibacterial compounds |
| 05/16/2002 | WO2002038595A2 Crystals and structure of luxs |
| 05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/16/2002 | WO2002038593A1 Haemophilus antigen |
| 05/16/2002 | WO2002038592A2 Peptides, the production and use thereof for binding immunoglobulins |
| 05/16/2002 | WO2002038588A2 Putrescine-n-methyltransferase promoter |
| 05/16/2002 | WO2002038587A2 Haplotypes of the grm8 gene |
| 05/16/2002 | WO2002038586A2 Haplotypes of the il6 gene |
| 05/16/2002 | WO2002038580A1 Streptavidin-binding peptides and uses thereof |
| 05/16/2002 | WO2002038179A1 Preventives or remedies for endoplasmic reticulum stress-associated diseases |
| 05/16/2002 | WO2002038177A2 Adjuvant combination formulations |
| 05/16/2002 | WO2002038174A2 Vaccines containing recombinant hantavirus proteins, methods for producing said vaccines and their use |
| 05/16/2002 | WO2002038173A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 05/16/2002 | WO2002038108A2 Methods of treating disorders related to apoe |
| 05/16/2002 | WO2002022814A3 Nucleotide sequences which code for the atr43 gene |
| 05/16/2002 | WO2002022658A3 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 05/16/2002 | WO2002020823A3 Methods and compositions for visualizing and interfering with chromosomal tethering of extrachromosomal molecules |
| 05/16/2002 | WO2002020760A3 Human vomeronasal receptor |
| 05/16/2002 | WO2002020054A3 Methods of treatment and diagnosis of hcv infection in cns based on magnetic resonance spectroscopy |
| 05/16/2002 | WO2002019968A3 Genetically engineered co-expression dna vaccines, construction methods and uses thereof |
| 05/16/2002 | WO2002018538A3 PROTOCOLS FOR THE GENERATION OF HIGH YIELD, SUPER-PRODUCTIVE TRANSGENIC PLANTS DISTURBED IN Ran/Ran-BINDING PROTEINS-MEDIATED CELLULAR PROCESS |
| 05/16/2002 | WO2002018427A3 Nucleotide sequences which code for the cita gene |
| 05/16/2002 | WO2002018413A3 Haplotypes of the scya2 gene |
| 05/16/2002 | WO2002017902A8 Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (dhcp), the protein encoded by same, and applications thereof |
| 05/16/2002 | WO2002016424A3 Dna binding peptide domains and a method for providing domains of this type |
| 05/16/2002 | WO2002012539A3 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/16/2002 | WO2002012292A3 Method of polypeptide renaturation |
| 05/16/2002 | WO2002011673A3 Methods of modulating activity of dxr |
| 05/16/2002 | WO2002006499A9 Zmaxig1-specific polynucleotides and methods of use |
| 05/16/2002 | WO2002006444A3 Isolated polynucleotide sequences encoding a fertility associated antigen |
| 05/16/2002 | WO2002004512A3 Purification of human troponin i |
| 05/16/2002 | WO2002002806A3 Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics |
| 05/16/2002 | WO2002002743A3 The nip3 family of proteins |
| 05/16/2002 | WO2002002598A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR18, AND USES THEROF |
| 05/16/2002 | WO2002000899A3 Heterologous gene expression in plants |
| 05/16/2002 | WO2001098364A3 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 05/16/2002 | WO2001098335A3 Transgenic algae for delivering antigens to an animal |
| 05/16/2002 | WO2001098314A3 Novel motor proteins and methods for their use |
| 05/16/2002 | WO2001096593A3 Novel motor proteins and methods for their use |
| 05/16/2002 | WO2001096398A3 Uncoupling proteins as targets for the treatment of heart failure |
| 05/16/2002 | WO2001096395A3 Biosynthetic oncolytic molecules and uses therefor |
| 05/16/2002 | WO2001096372A3 Zinc transporters proteins and their use in medicinal preparations |
| 05/16/2002 | WO2001094384A3 A rhodopsin-like protein extractable from the photoreceptor of euglena gracilis, for use in the preparation of opto-electronic devices |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001092469A3 Phosphorylated polypeptides and uses related thereto |
| 05/16/2002 | WO2001092291A3 Antibody and t-cell receptor libraries |
| 05/16/2002 | WO2001090183A3 Human secreted protein, zsig47 |
| 05/16/2002 | WO2001088533A3 Lipid uptake assays |
| 05/16/2002 | WO2001087903A3 Haplotypes of the acaa1 gene |
| 05/16/2002 | WO2001086003A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 05/16/2002 | WO2001085933A3 Plakoglobin interacting proteins |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001083552A3 Human sez6 nucleic acids and polypeptides |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081622A8 Diagnosis of diseases associated with dna repair |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001081405A3 Methods and compositions for the prevention and treatment of anemia |
| 05/16/2002 | WO2001080879A3 Colorectal cancer vaccines and diagnosis |
| 05/16/2002 | WO2001079518A3 Codon optimisation for expression in retrovirus packaging cells |
| 05/16/2002 | WO2001079492A3 Lipid binding protein 3 |
| 05/16/2002 | WO2001077329A3 Human twik molecules and uses thereof |
| 05/16/2002 | WO2001077171A3 Soluble zalpha11 cytokine receptors |
| 05/16/2002 | WO2001074857A3 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 05/16/2002 | WO2001074852A3 Protein having activity as an angiogenesis modulator |
| 05/16/2002 | WO2001073444A3 Receptor/peptide crystal structure for identification of inhibitors |
| 05/16/2002 | WO2001073083B1 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 05/16/2002 | WO2001072842A3 Human 7-transmembrane proteins and polynucleotides encoding the same |
| 05/16/2002 | WO2001069261A3 Proteins, genes and their use for diagnosis and treatment of vascular dementia |
| 05/16/2002 | WO2001068699A3 Regulation of human neuropeptide y-like g protein-coupled receptor |
| 05/16/2002 | WO2001066598A3 Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods |
| 05/16/2002 | WO2001055317A8 Nucleic acids, proteins, and antibodies |
| 05/16/2002 | WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 05/16/2002 | WO2001044299A3 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001039802A9 Chimeric flavivirus vaccines |
| 05/16/2002 | WO2001034823A9 Method for enhancing resistance in plants |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | WO2001032002A9 Myb transcription factors and uses thereof |